During the past decade, The First People's Hospital of Nanning conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The First People's Hospital of Nanning" are "Coronary Heart Disease" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "The First People's Hospital of Nanning" in a lesser frequency.

Most popular intervention types in "The First People's Hospital of Nanning" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dual anti-platelet therapy" (1 trials), "Metformin Hydrochloride" (1 trials), "Single anti-platelet therapy" (1 trials), "TQZ2451" (1 trials) and "Victoza®." (1 trials). Other intervention names were less common.

The vast majority of trials in "The First People's Hospital of Nanning" are 2 trials for "All" genders.

Currently, there are NaN active trials in "The First People's Hospital of Nanning". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The First People's Hospital of Nanning, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The First People's Hospital of Nanning, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".